Cite
HARVARD Citation
Tardy, B. et al. (2022). Revised terminal half‐life of nonacog alfa as derived from extended sampling data: A real‐world study involving 64 haemophilia B patients on nonacog alfa regular prophylaxis. Haemophilia. 28 (4), pp. 542-547. [Online].